- Home
- NMTC vs INKT Comparison
NMTC vs INKT Comparison
Compare NMTC & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- INKT
- Stock Information
- Founded
- NMTC 2009
- INKT 2017
- Country
- NMTC United States
- INKT United States
- Employees
- NMTC N/A
- INKT N/A
- Industry
- NMTC Medical/Dental Instruments
- INKT Medicinal Chemicals and Botanical Products
- Sector
- NMTC Health Care
- INKT Health Care
- Exchange
- NMTC Nasdaq
- INKT Nasdaq
- Market Cap
- NMTC 33.8M
- INKT 28.8M
- IPO Year
- NMTC N/A
- INKT 2021
- Fundamental
- Price
- NMTC $0.74
- INKT $41.04
- Analyst Decision
- NMTC Strong Buy
- INKT Strong Buy
- Analyst Count
- NMTC 1
- INKT 2
- Target Price
- NMTC $1.45
- INKT $37.50
- AVG Volume (30 Days)
- NMTC 178.3K
- INKT 2.4M
- Earning Date
- NMTC 08-13-2025
- INKT 08-12-2025
- Dividend Yield
- NMTC N/A
- INKT N/A
- EPS Growth
- NMTC N/A
- INKT N/A
- EPS
- NMTC N/A
- INKT N/A
- Revenue
- NMTC $5,758,777.00
- INKT N/A
- Revenue This Year
- NMTC $157.28
- INKT N/A
- Revenue Next Year
- NMTC $41.79
- INKT N/A
- P/E Ratio
- NMTC N/A
- INKT N/A
- Revenue Growth
- NMTC 54.53
- INKT N/A
- 52 Week Low
- NMTC $0.40
- INKT $4.56
- 52 Week High
- NMTC $1.39
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- NMTC 60.04
- INKT 69.01
- Support Level
- NMTC $0.71
- INKT $6.80
- Resistance Level
- NMTC $0.77
- INKT $76.00
- Average True Range (ATR)
- NMTC 0.05
- INKT 4.65
- MACD
- NMTC 0.00
- INKT 4.24
- Stochastic Oscillator
- NMTC 65.90
- INKT 49.48
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.